Notable Analyst Rating Changes 11/24: ABG, PRU, RS, AYI, AMLN, TLAB Upgraded; DELL, CIEN, UNP, ALV Downgraded
More News related to ABG
- Asbury Automotive Group Schedules Release of Fourth Quarter and Year-End Financial Results and Conference Call
- Asbury Automotive Group Selects Porter Novelli as Public Relations Agency of Record
- Unusual 11 Mid-Day Movers 11/24: IWA, DRAM, ABG, TIXC Higher; WH, WMG, ABIO, NYNY Lower
- Notable Analyst Rating Changes 11/24: ABG, PRU, RS, AYI, AMLN, TLAB Upgraded; DELL, CIEN, UNP, ALV Downgraded
- Deutsche Bank upgrades Asbury Automotive (ABG) to Buy; Increased Confidence After Meeting W/Mgmt
More News related to ALTH
- Allos Therapeutics to Present at BIO CEO & Investor Conference
- BioCentury Publishes BioTech Picks for FY10 (HGSI, VRTX, AMGN, More...)
- BioCentury Publishes Investor Picks for New Biotech Bellwethers in 2010
- Notable Analyst Rating Changes 1/8: HAL, AMAT, JCP, AGU, ESV, RDN, More Upgraded; M, KO, STX, ERIC, WEN, PCS, More Downgraded
- J.P. Morgan Intiates Coverage on Allos Therapeutics (ALTH) with a Buy
More News related to ALV
- Notable Analyst Rating Changes 02/01: BIDU, ALV, G, ARG, ASH Upgraded; CPF, M, LZ, COGT, WCRX Downgraded
- Morning Movers 2/1: CNLG, VCI, ALV Higher; EBR, FSNM, SMTB Lower
- Gabelli Upgrades Autoliv (ALV) to Buy
- Deutsche Bank Upgrades Autoliv (ALV) to Buy; Valuation Call
- Autoliv (ALV) Posts Q4 EPS of $1.39, Tops Views
More News related to Special Reports
- Notable Analyst Rating Changes of the Day 02/10: DELL, GET, TIF, OPEN Upgraded; SU, BTU, TLVT, SLT Downgraded
- Morning Movers 2/10: ATHX, CYBI, LIOX, OPEN, NTGR Higher; ISIS, DF, RTK Lower
- Notable Mergers and Acquisitions of the Day 02/10: MU, GE, ORCL
- After-Hours Movers 2/9: MCZ, NTGR, CYBI, BIDU, RMTR, FNSR Higher; QUIK, LGF, APPY, VRUS, EXBD Lower
- Trading Radar for 02/10: Sprint (S), Dean Foods (DF), Scripps Networks (SNI), Vale S.A. (VALE), Level 3 Comm (LVLT) Report
UPGRADES:
Deutsche Bank upgrades Asbury Automotive (NYSE: ABG) from Hold to Buy. Price target to $14.50 from $13.50. Click here. for more color.
Wells Fargo upgrades Prudential Financial, Inc. (NYSE: PRU) from Market Perform to Outperform. Raises valuation range to $58-64 from $47-51 per share. Click here to see full color on the upgrade.
UBS upgrades Reliance Steel & Aluminum Co. (NYSE: RS) from Neutral to Buy.
Oppenheimer upgrades Acuity Brands Inc. (NYSE: AYI) from Perform to Outperform. The firm cited recent relative weakness and increased conviction on traction in market share strategies, other growth initiatives, and some areas of potential comparison benefits in FY10.
Barclays upgrades Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) from Equal Weight to Overweight and raised their price target from $16 to $22. Here is more color.
Soleil Securities upgrades Tellabs (NASDAQ: TLAB) from Hold to Buy. Price target $7.25. Click Here for more color.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
First Global have downgraded shares of Dell (NASDAQ: DELL) from Moderate Outperform to Market Perform this morning. For more color, Click Here.
Jefferies & Co downgrades Ciena Corp (Nasdaq: CIEN) from Hold to Underperform.
UBS downgrades Union Pacific (NYSE: UNP) from Buy to Neutral. The firm maintained a $67 price target.
Bank of America downgrades Autoliv (NYSE: ALV) from Neutral to Underperform. Price target $38. KeyBanc also downgraded Autoliv Inc. from Buy to Hold. Price target $41. Click Here to see more color from KeyBanc.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Wells Fargo initiates coverage on Activision Blizzard, Inc. (Nasdaq: ATVI) with an Outperform, $14-16 Valuation Range. Click Here for more color.
Morgan Joseph initiates coverage on St. Jude Medical Inc. (NYSE: STJ) with a Buy. Price target $42. For more color, Click Here.
Wells Fargo initiates coverage on Electronic Arts, Inc. (Nasdaq: ERTS) with a Market Perform rating. Price range $17-19. Click Here for more color.
Jefferies & Co initiates coverage Alpha Natural Resources (NYSE: ANR) with a Buy. Price target $50.
ThinkEquity initiates coverage on Allos Therapeutics (Nasdaq: ALTH) with a Buy rating.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
-0.09
+0.15Related Entities
- Deutsche Bank
- UBS
- KeyBanc
- Jefferies & Co
- Soleil Securities
- Banc of America
- ThinkEquity
- Morgan Joseph
- Barclays
- Notable Analyst Rating Changes
- EIM Group
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
